Pain Medicine, Interventional Pain Medicine · Pasadena, TX
NPI
1578584355
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5010 Crenshaw Rd, Ste. #130
Pasadena, TX, 77505
Phone (281) 991-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$261K
3,294 services
Medicare patients, 2024
873
Average age 75
Drug cost, 2024
$673K
15,295 prescriptions
Company payments, 2025
$1,063
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose R Reyes Jr. was code 99309 (snf e&m), 1,114 times for 318 patients. In total Jose R Reyes Jr. billed 3,294 services in 45 codes, and Medicare paid $261K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 1,114 | 318 | $79.32 | $88K |
| 99232 Hospital E&M - Subsequent | Facility | 712 | 307 | $58.34 | $42K |
| 99214 Office E&M - Established | Office | 471 | 224 | $86.05 | $41K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 296 | 167 | $57.22 | $17K |
| 80307 Drug Tests | Office | 107 | 75 | $58.90 | $6,303 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 96 | 67 | $193.04 | $19K |
| 99306 SNF E&M | Facility | 92 | 88 | $133.69 | $12K |
| 99223 Hospital E&M - Initial | Facility | 57 | 56 | $126.95 | $7,236 |
| 99233 Hospital E&M - Subsequent | Facility | 55 | 55 | $86.75 | $4,771 |
| 96127 Behavioral Health Services | Office | 44 | 37 | $3.30 | $145 |
| 99204 Office E&M - New | Office | 19 | 19 | $113.17 | $2,150 |
| 64483 Nerve Block Injection - Back | Office | 18 | 16 | $90.68 | $1,632 |
| 64494 Nerve Block Injection - Back | Office | 17 | 12 | $56.19 | $955 |
| 62321 Nerve Block Injection - Back | Office | 16 | 13 | $71.36 | $1,142 |
| 64493 Nerve Block Injection - Back | Office | 15 | 11 | $99.78 | $1,497 |
By year: 2022 $326K for 3,824 services; 2023 $356K for 3,874 services; 2024 $261K for 3,294 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 107 | 75 | $58.90 | $6,303 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 96 | 67 | $193.04 | $19K |
Medicare prescription drug claims, 2024
In 2024, the drug Jose R Reyes Jr. prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 7,596 prescriptions and refills. In total Jose R Reyes Jr. wrote 15,295 Medicare prescriptions that cost $673K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 7,596 | 7,603 | 1,246 | $224K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,199 | 1,203 | 221 | $29K |
| Tramadol Hcl Generic | 734 | 737 | 266 | $5,550 |
| Gabapentin Generic | 634 | 664 | 237 | $7,264 |
| Oxycodone Hcl Generic | 612 | 612 | 117 | $11K |
| Tizanidine Hcl Generic | 561 | 612 | 211 | $3,778 |
| Pregabalin Generic | 521 | 551 | 191 | $13K |
| Morphine Sulfate Er Morphine Sulfate | 495 | 495 | 83 | $12K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 468 | 470 | 157 | $9,049 |
| Fentanyl Generic | 197 | 197 | 27 | $23K |
| Cyclobenzaprine Hcl Generic | 190 | 198 | 66 | $1,541 |
| Hydromorphone Hcl Generic | 186 | 186 | 32 | $3,903 |
| Methocarbamol Generic | 149 | 149 | 73 | $2,007 |
| Meloxicam Generic | 135 | 159 | 53 | $579 |
| Xtampza Er Oxycodone Myristate | 130 | 130 | 20 | $66K |
Brand drugs: 504 claims; generic drugs: 14,791 claims; opioid claims: 12,151.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose R Reyes Jr. $1,063 ($1,063 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbott Laboratories with $340.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 23 | $340 |
| Collegium Pharmaceutical, Inc. COLL | 12 | $203 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $117 |
| Saluda Medical Americas, Inc. | 3 | $85.74 |
| Pfizer Inc. PFE | 2 | $51.62 |
| Valinor Pharma, LLC | 3 | $50.39 |
| Medtronic, Inc. MDT | 1 | $48.6 |
| Lundbeck LLC | 2 | $37.47 |
| SPR Therapeutics, Inc | 2 | $29.11 |
| Nalu Medical, Inc. | 1 | $24.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.